Steven Perrin

Steven Perrin

Patrimonio netto: 3 810 $ in data 31/05/2026

61 anni
Health Technology
Consumer Services
Commercial Services

Profilo

Steven N.
Perrin
is the founder of Anelixis Therapeutics, Inc., founded in 2013, where the titles held included President, CEO, Treasurer & Director.
Current jobs include Executive Chairman at ALS Therapy Development Foundation, Inc. since 2018 (job started in 2007) and President, Chief Scientific Officer & Director at Eledon Pharmaceuticals, Inc. since 2020.
Former jobs include Associate Director-Molecular Profiling at Biogen, Inc. from 2001 to 2006, Scientist at Biogen MA, Inc., ARIAD Pharmaceuticals, Inc., and Aventis Pharmaceuticals, Inc., Assistant Professor at Boston University, Principal at Hoechst Ariad Genomics Center Llc, and Associate Professor at Boston University School of Medicine.
Education includes an undergraduate degree from Boston College in 1987 and a doctorate from Boston University School of Medicine in 1994.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
31/03/2026 1.000 ( 0% ) 3 810 $ 31/05/2026

Posizioni attive di Steven Perrin

SocietàPosizioneInizio
ELEDON PHARMACEUTICALS, INC. Presidente 14/09/2020
Presidente 01/06/2010

Precedenti posizioni note di Steven Perrin

SocietàPosizioneFine
BIOGEN INC. Corporate Officer/Principal 01/12/2006
Corporate Officer/Principal -
Fondatore -
Corporate Officer/Principal -
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Steven Perrin

Formazione di Steven Perrin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

85

Relazioni di 1° grado

11

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private11

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Commercial Services

Consumer Services

Health Technology

Consumer Services

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. Steven Perrin
ULTIMI ORARI | -40%: I migliori strumenti riservati agli abbonati per identificare i migliori investimenti di domani!
g
:
:
ENTRA ORA